Institute For Pharmaceutical 2022-2023 Fellowship Program

Transcription

Institute for PharmaceuticalIndustry Fellowships2022-2023 Fellowship Program

Table of ContentsAbout Bayer Leadership Team Consumer Health Division Consumer Health Program Global Innovation & Product Development Medical & Clinical Affairs Rx-to-OTC Switch Science Pharmacovigilance Risk Management Pharmaceuticals Division Pharmaceutical Program Oncology Development Operations Global Regulatory Affairs Medical Affairs Communications Medical Science Liaison, Oncology 3-678-128910111213-271314151617US Marketing: Cardiovascular and Renal Franchise US Oncology Marketing Global Medical Affairs, Oncology Business Development & Licensing Global Oncology Training and Commercial Excellence New Product Commercialization & Portfolio Strategy US Market Access Global HEOR/Market Access US Translational Study Operations (TSO) US Marketing: Specialty Franchise Directory of Fellows Bayer Fellowship Alumni Currently Employed at Bayer Rutgers Pharmaceutical Industry Fellowship 1819202122232425262728-293031-332022-2023 Fellowship Program2

About BayerMore than 150 Years of HistoryGerhard Domagkdiscovered thetherapeutic effect ofsulfonamides, with oneOn August 1, 1863, dye salesmanactive ingredient fromFriedrich Bayer and master dyerthis class of substancesJohann Friedrich Weskott founded thebeing launched in 1935 as Prontosil – ageneral partnership “Friedr. Bayer etkey breakthrough in the chemotherapy ofcomp.,” and the company grew toinfectious diseases for which Domagk receivedbecome a joint stock company in 1881.the Nobel Prize in 1939.1863-1881: The Early Years1925-1945: A Time of Inventions1881-1914: Becoming an InternationalCompanyBayer acquired the North AmericanIn 2010, Bayer celebrated fifty years ofself-medication business of Sterlingsuccessful family planning with the pill: firstWinthrop in 1994. In 1995, the U.S.-given regulatory approval in 1960. Till this daybased Miles Inc. was renamed BayerBayer is a global market leader in the field ofCorporation.hormonal contraception.1988-2001: Transformationand Globalization2010-2014: Pioneers in Women'sHealth1974-1988: Expansion ofPharmaceutical Research2001-2010: Reorganization and GrowthBayer develops into a chemicalSuccessful products to emerge from Bayer'sBayer completes the acquisition of thecompany with international operations.research laboratories in this period included theRoche consumer health business in JanuaryResearch efforts gave rise tocardiovascular drug Adalat , Bayer's first broad-2005, advancing to become one of thenumerous intermediates, dyes andspectrum antibiotic from the class of quinolonesworld’s top suppliers of nonprescriptionpharmaceuticals, including the "DrugCiprobay andmedicines. In December 2005, the U.S. FDAof the Century," Aspirin , which wasthe antifungal cropapproves Nexavar for the treatment ofdeveloped by Felix Hoffmann andprotection productadvanced renal cell carcinoma.launched onto the market in 1899.Bayleton .In December of 2009, a Bayer teamwins the German Future Prize for thedevelopment of the new anticoagulant(Xarelto )*.* not marketed by Bayer in the U.S.2014 - present: Investing in theFutureBayer strengthensits oncologybusiness withthe acquisition ofAlgeta in March2014. In October of the same year, Bayeracquires the consumer care unit of U.S-basedMerck & Co. More recently in 2019, throughthe full acquisition of BlueRock Therapeutics,Bayer is committed to building a leadingposition in cell therapy.2022-2023 Fellowship Program3

About BayerProduct Portfolio*PharmaceuticalsConsumer Health* Not all of these products are marketed by Bayer in the U.S2022-2023 Fellowship Program4

About BayerBayer’s LIFE ValuesBy working sustainably and accepting our role as a socially and ethically responsiblecorporate citizen – and by committing to our Bayer values – we create benefits for thecommunities in which we live.Science For A Better Life: this is the promise we all give to our ncyLeadership means much moreFollowing the rules of law andIn today’s everchangingEfficiency implies our overallthan retaining and extendingregulations is a given to Bayer.business landscape, the abilityapproach to make the bestour market positions. It appliesOur integrity enhances theto adapt to different situationspossible use of our resources,to all our employees, not justlegitimacy of our operations andis crucial for future success.thus improving our overallmanagers.strengthens our reputation.performance.2022-2023 Fellowship Program5

About BayerThe 4 Focus BehaviorsOur Purpose “Science for a Better Life” is all aboutWHY we exist as a company, while strategy isabout WHAT we do. Focusing on culture answersHOW we are going to achieve this. The 4 FocusBehaviors are derived from the LIFE values andare the behaviors we want to reinforce:Customer Focusis what drives ourbusiness and ensuresthat we can deliver on ourpurpose “Science for abetter life”.ExperimentationCollaboration is theis a pre-requisite forfoundation of our newinnovation. Innovationoperating model.ensures business successtomorrow.Trust is theoil that fuels theorganizational engine oftransformative leadership,empowerment and highperformance.2022-2023 Fellowship Program6

Leadership TeamProgram DirectorsExecutive SponsorsYasmin Islami, MBAMark Rametta, DO, FACOI, FACPMedical Director in U.S. MedicalAffairs-NeurologyVP & Head, New Product Commercialization andPortfolio StrategyTodd Paporello, PharmD, MBAVice President & HeadRegulatory Affairs AmericasResearch & Development Site HeadLutz Petersdorf, M.D., PhDVP, Global Medical Category Allergy & Cough/Cold, Pain & Cardio and Region LATAM,Consumer HealthConsumer ProgramDirectorPharmaceutical Program DirectorsSuzette ThomasPharmD, MSDirector, Medical AffairsCommunication, Women'sHealthcareAlyson Andrikanich,PharmDDirector, Advertising & PromotionRegulatory Affairs AmericasTy Van Slooten, MBAU.S. Head of Study Management,Clinical SciencesLars BuggertSenior Director Clinical ProjectManagement OncologyJim Serpico, RPh, MBASenior Director, Brand PortfolioStrategy & Patient Marketing, USRare Disease MarketingAzita Tajaddini, PhDSenior Associate Director, Global MedicalCategory Pain, Consumer Health2022-2023 Fellowship Program7

Bayer Consumer Health DivisionConsumer Health ProgramCONSUMER HEALTHBayer Consumer Health, with its U.S. headquarters in Whippany, New Jersey, is among the top consumer healthcarecompanies in the world. At Bayer’s Consumer Health division, our vision is to make self-care for a better life a reality forbillions of people around the world through everyday healthcare. Our strategy is aimed at further building our strongposition in the market for OTC medicines, nutritional supplements and other self-care products in selected categories.2022-2023 Fellowship Program8

Bayer Consumer Health DivisionGlobal Innovation & Product Development2 YEAR FELLOWSHIPRECRUITING 1 FELLOW Formulation Development Rotation:- Design and implement pre-formulation, formulation process, and project timelines for newproducts using Quality by Design principles- Participate in consumer insight studies for new product ideation and product design sessions- Help design and refine prototypes with the consideration of product stability, regulatory andmedical acceptability for innovative Bayer Consumer Health productsJerry MeiselVP, Global Product DevelopmentPreceptor Technology Transfer Rotation:- Perform experiments in the GMP pilot plant to test final formulation, develop a manufacturingprocess, and scale-up the product- Collaborate with cross-functional team members to optimize formulation for small scale, pilotscale, and commercial scale manufacturing- Manufacture experimental, registration, and validation batches for potential marketed products CMC Strategy and Documentation Rotation:- Author, review, and update chemistry, manufacturing, and controls (CMC) sections (Module 3) andquality overall summaries for new and registered products- Assess regulatory impact for proposed product changes variations and impact to manufacturingsites (including changes to processes, specifications, testing, packaging, and raw materials).Magid Youssef, PharmD, BSChemical EngineeringRutgers University Ernest MarioSchool of Pharmacy2nd Year FellowKarmen Wong, PharmDUniversity of Hawaii1st Year Fellow- Collaborate with regulatory colleagues, manufacturing sites, I&D unit and product supply to alignon CMC strategy and documentation for new and registered products- Respond to health authority CMC queries on new or registered products and provide technicaljustifications based on global and local regulations- Provide CMC gap analysis, risk assessments, and technical justifications based on global and localregulations2022-2023 Fellowship Program9

Bayer Consumer Health DivisionMedical & Clinical Affairs2 YEAR FELLOWSHIPRECRUITING 2 FELLOWS Interact with both Global and North American medical teams to propelthe consumer health business through scientific insights and to supportnew product and claims innovation Develop new claims and indications for OTC drugs, nutritionals, medicaldevices, and/or cosmetic products to support Marketing Design study protocols and support clinical research activities usingrigorous scientific methodologies and Good Clinical Practice (GCP)Lutz I. Petersdorf, M.D., PhDVice President & Head Global Medical Category Allergy &Cough/Cold, Pain & Cardio and Region LATAMExecutive Sponsor Consumer HealthAzita Tajaddini, PhDSr. Associate Director in Global Medical Category PainProgram Director Consumer Health Maintain knowledge of scientific and clinical data to support currentlymarketed products and to challenge competitor products Collect, review, assess, and disseminate scientific and clinical informationrelated to the company products or competitive products Review promotional materials with cross-functional team members toensure medical, legal, regulatory and commercial objectives are met Provide support for the strategy, coordination, and implementation ofadvisory board meetings and FDA advisory committee meetingsEngy Mikhail, PharmD, RPhRutgers University Ernest Mario School of Pharmacy2nd Year FellowFatima Sajjad, PharmDRutgers University Ernest Mario School of Pharmacy2nd Year Fellow Interact and collaborate with key opinion leaders Attend scientific meetings to present data and to provide scientificsupport at medical booths Lead drafting and submission of scientific publications Develop and present scientific training material for sales, marketing andcustomer teamsLora Gawargi, PharmDRutgers University Ernest Mario School of Pharmacy1st Year Fellow2022-2023 Fellowship Program10

Bayer Consumer Health DivisionRx-to-OTC Switch Science2 YEAR FELLOWSHIPRECRUITING 1 FELLOW Support all phases of a Switch project in the role of a Switch Teammember through assisting with:- Development of Strategy for Switch programs- Assessment of new prescription molecules for Switch potential- Providing scientific/medical support for preliminary commercialassessmentsMaggie Gandhi, PharmD,MBA, RPhAssociate Director, Rx to OTC SwitchScience Preceptor- Drafting regulatory dossiers- Contributing to Consumer Behavior research to support Switchprograms- Technology-enablement and innovation applied to switch of moleculesin need of special requirements beyond the traditional path to market,i.e. Drug Facts Labeling Key interfaces:- Bayer Pharmaceutical functions- Licensing partnersSanjukta Basu, PharmD, RPh, MBAFairleigh Dickinson University2nd Year Fellow- Global Functions and Resources Supporting Pharmaceuticaland Consumer Health, e.g. Medical Affairs, Safety/Toxicology,Pharmacovigilance, Pharmacoepidemiology, Clinical Operations, R&DInformation Center, Consumer Science, Development Centers ofExcellence, Regulatory Affairs2022-2023 Fellowship Program11

Bayer Consumer Health DivisionPharmacovigilance Risk Management2 YEAR FELLOWSHIPNOT RECRUITING Work in a global safety environment applying skills and knowledge in amulti-national regulatory environment Collaborate with colleagues in medical affairs, clinical development, andregulatory affairs to conduct benefit risk assessments Align with commercial and medical project management teams todevelop risk mitigation strategies in support of bringing new productsto marketMaria Micheludis, MS, RPhGlobal Safety LeaderPreceptor Prepare safety assessments for new and existing products includingmedicinal, nutritional, cosmetic, and medical device products marketedworldwide. Contribute to the preparation of a variety of scientific and regulatorydocuments including Common Technical Documents, PeriodicBenefit-Risk Evaluation Reports, Risk Management Plans, and labelingjustification documentsAndrew Piracha, PharmD, RPhSt. John's University2nd Year Fellow2022-2023 Fellowship Program12

Bayer Pharmaceuticals DivisionPharmaceutical ProgramPHARMACEUTICALSThe U.S. Bayer Pharmaceuticals business,headquartered in Whippany, New Jersey, focuseson researching, developing and marketing specialtyfocused innovative medicines in the therapeutic areasof cardiology, oncology, gynecology, hematology,and ophthalmology. In this way, we are addressingthe growing requirements of patients, physicians,healthcare payers and regulatory agencies. With ourinnovative products, we seek to achieve therapeuticbenefit for patients, while at the same time satisfyingthe growing requirements of physicians and healthinsurers.2022-2023 Fellowship Program13

Bayer Pharmaceuticals DivisionOncology Development Operations2 YEAR FELLOWSHIPRECRUITING 1 FELLOW Manage all activities related to global and/or local clinical trials fromthe study concept to the Clinical Study Research report Participate in the Study Team, from requesting core study teammembers to study close-out contributions, with regard to itsoperational aspectsLars BuggertSenior Director Clinical Project ManagementOncology Program Director Develop a comprehensive overview and operational plans for thestudy by developing and maintaining the Study Plan Contribute to risk management activities of Global Clinical Teamand responsible for study oversight and risk mitigation activities asdescribed in the Study Plan Support the strategic study feasibility and manage operational studyfeasibility conducted by country organization to determine studyfeasibility and final country selection Develop study timelines, milestones, outsourcing plan andproposed external study budget based on feasibility summaryZhaoping YanLead Study ManagerPreceptorBree JasminskiStudy ManagerPreceptorGina Fu, PharmD, MBAStudy ManagerPreceptor Work in close collaboration with the study team to develop corestudy documents and processes Create the total external study budget and provide monthly andyearly budget estimatesMiriam Fakhry, PharmD, RPhRutgers University Ernest MarioSchool of Pharmacy2nd Year FellowDebbie Li, PharmD, RPhWashington State University2nd Year Fellow2022-2023 Fellowship Program14

Bayer Pharmaceuticals DivisionGlobal Regulatory Affairs - Strategy2 YEAR FELLOWSHIPRECRUITING 3 FELLOWS Lead and support interactions with global Health Authorities (e.g. FDA, EMA) through thepreparation of regulatory dossiers including Investigational New Drug (IND) applications,New Drug Applications (NDAs), Biologics License Applications (BLAs), Clinical TrialApplications (CTAs), and Marketing Authorization Applications (MAAs) Work with Global Regulatory Team members to develop regulatory strategy and guideGlobal Project Teams Coordinate team activities to obtain written and oral Health Authority feedback on drugdevelopmentTodd Paporello, PharmD, MBAAlyson Andrikanich, PharmDVice President & HeadRegulatory Affairs AmericasResearch & Development Site HeadDirector, Advertising & Promotion RegulatoryAffairs AmericasJessica Xiao, PharmDNamosha Mohite, PharmD Maintain marketed products including all labeling and promotional activities in compliancewith regulatory requirements Therapeutic Areas of Opportunity: Global Regulatory Strategy (U.S. & International) inCardiology, Nephrology & Thrombosis; Hematology; Oncology; Ophthalmology; Pulmonology& Anti-infectives; and Women’s Health Care Fellow can also gain exposure to other areas of regulatory including: U.S. Advertising andPromotion, Global Labeling, Regulatory Intelligence & Analytics, Global CMC management(drugs & biologics), and Submission Planning and ManagementRutgers UniversityErnest Mario School of Pharmacy2nd Year FellowSt. John's University1st Year Fellow2022-2023 Fellowship Program15

Bayer Pharmaceuticals DivisionMedical Affairs Communications2 YEAR FELLOWSHIPRECRUITING 2 FELLOWS Collaborate with cross-functional team members to ensure advertisingand promotional materials meet legal, medical, regulatory and commercialobjectives Review advertising and promotional materials to ensure medical accuracy Provide balanced, written and verbal scientific responses to inquiries fromhealthcare professionals in a compliant mannerMark Rametta, DO,FACOI, FACPMedical Director in U.S.Medical Affairs NeurologyWagdy Youssef, M.D,MBASenior Director, Medical AffairsCommunicationsLarry McCullum, PharmD, RPhDirector, Medical AffairsCommunications, Oncology PrecisionMedicine Franchise/Oncology PipelinePreceptor Research medical literature and evaluate scientific data to develop evidencebased medical content for responsesValentina Pampulevski,PharmD, RPhDirector, MedicalCommunications and DigitalTransformationPreceptor Conduct longitudinal research in medical communications to be presented atan industry-wide conference Provide medical information booth support at medical conferences Develop medical educational materials and present lectures to crossfunctional colleaguesStephen Paine, MBA, RPhDirector, Medical AffairsCommunication, HematologyPreceptor Identify, document, and report adverse events and product complaintsShadey Elgndy, PharmDUniversity of Maryland, EasternShore2nd Year FellowSaleemSuzette Thomas, PharmD, MSNoormohamed, PharmD, MBADirector, Medical AffairsDirector, Medical AffairsCommunications, OncologyPreceptorCommunication, Women's HealthcarePreceptorMafaza Qaiser, PharmD , RPhRebecca Palma, PharmDFairleigh Dickinson University2nd Year FellowUniversity of Conneticut1st Year FellowTara Pummer, PharmDDirector, Medical AffairsCommunication, CardioRenalPreceptorTanvi Lodhia, PharmDRutgers University Ernest MarioSchool of Pharmacy1st Year Fellow2022-2023 Fellowship Program16

Bayer Pharmaceuticals DivisionMedical Science Liaison, Oncology1 YEAR FELLOWSHIPRECRUITING 1 FELLOW The Fellow will work with the U.S. Medical Affairs Oncology organization during their tenure inthe Fellowship Program Build a strong foundational background in the oncology therapeutic area and learn how toeffectively communicate advanced scientific data on clinical research, disease state awareness,pipeline assets, and therapeutic trends in a fair balanced mannerCynthia Quince, PharmDNational MSL Director – OncologyProgram Director Gain an understanding of the Medical Science Liaison (MSL) role including thought leader (TL)engagement planning, mapping, territory management and the art of developing and fosteringrelationships with critical stakeholders, TLs, Health Care Professionals (HCPs) and institutions Learn field medical trends and contribute actively to team projects of high impact to the MSLteam Attend and actively participate in relevant scientific and professional meetings, including majormedical meetings and Bayer Advisory Boards Participate in the review process and discussion strategy for Investigator Initiated Research(IIR) as well as Company Sponsored Studies (CSS)Michael McGlynn, PharmDDirector, Medical Affairs Oncology MSLPreceptorJohn Henaen, PharmD, MBA, RPhFarleigh Dickinson University1st Year Fellow2022-2023 Fellowship Program17

Bayer Pharmaceuticals DivisionUS Marketing: Cardiovascular and Renal Franchise2 YEAR FELLOWSHIPRECRUITING 1 FELLOWPHARMD/MBA PREFERRED Contribute to the execution of Brand commercial activities in the U.S., across healthcareprofessional, patient and digital marketing channels Ensure cross-functional alignment in brand planning and tactical execution with keystakeholders, including Market Access, Medical Affairs, Sales Training and Sales Participate in all aspects of promotional campaigns and other initiatives for KERENDIA(finerenone)Jim Serpico, PharmD, MBA, RPhImtiaz HussainSenior Director, Brand Portfolio Strategy &Patient Marketing, US Rare Disease Marketing,Program Director,PreceptorSenior Director, Launch Management,Cardiovascular/RenalPreceptorLisa MancerScott Beeman, PharmD, MBA, RPh Compile primary and secondary competitive intelligence and provide data analyses/reports to Brand and Senior Leadership Engage in market research activities, and report topline to Brand and Senior Leadership Assist in preparing business unit (BU) and Brand commercial assumptions andrecommendations for co-promotion, co-development and other partnershipopportunitiesDirector, Cardiorenal Patient MarketingPreceptorElla Mokrushin, PharmD, MBACalifornia Northstate University2nd Year FellowDirector, US Cardiorenal MarketingPreceptorBassel Fattal, PharmD, MBAFarleigh Dickinson University1st Year Fellow2022-2023 Fellowship Program18

Bayer Pharmaceuticals DivisionUS Oncology Marketing2 YEAR FELLOWSHIPRECRUITING 2 FELLOWS Gain hands-on experience within the US Oncology Marketingdepartment Support the development and implementation of marketingmaterials Manage healthcare provider and patient-focused marketinginitiativesLisa DesideratoVP of Marketing, US OncologyProgram DirectorHilary MuldoonSenior Director, Oncology Portfolio MarketingPreceptorSimon RosofVP of Prostate Cancer MarketingPreceptor Coordinate with Marketing and External Agencies inexecution and management of marketing tactics (e.g. adboards, promotional review team submissions, etc.) Critically analyze data/publications and provide support toMarketing, Sales, and Sales Training Participate in the brand/launch planning process Collaborate with cross-functional partners, including Training,Market Access, and Sales colleagues in preparation for newproduct launch or expanded indicationsSaurabh JohriVP Targeted Medicine Bayer OncologyPreceptorRaj JainSenior Director, Oncology Patient MarketingPreceptorPrince-Harry Mangondato,PharmDRutgers UniversityErnest Mario School of Pharmacy2nd Year Fellow Engage in market research activities, competitive intelligencegathering, and overall project management Supporting review of marketing materials through thepromotional review process with legal, medical, andregulatory colleaguesVictoria Hoang, PharmDRutgers University Ernest Mario School ofPharmacy1st Year FellowBenedicta Ojibah, PharmDPurdue University1st Year Fellow2022-2023 Fellowship Program19

Bayer Pharmaceuticals DivisionGlobal Medical Affairs, Oncology2 YEAR FELLOWSHIPRECRUITING 1 FELLOW Develop a deep understanding of the importance and relevance of the Global Medical Affairs (GMA)department to the broader organization, and how all GMA functions work together to support an overallbrand strategy Understand the local/regional medical affairs strategies, and how GMA support these strategies Gain a thorough understanding of the scope of Scientific Communications activities and how these taskssupport the overall Medical Affairs and brand strategiesYaswant Dayaram, PhDExecutive Director & Head,Oncology Publications and Medical InquiriesProgram Director Gain a comprehensive understanding of data generation and analysis, Good Publication Practicesincluding prevailing industry standards in Medical Publications, Bayer’s Publication Policy and BestPractices Obtain a direct experience in interpreting and appropriately responding to medical inquiries posed byhealth care professionals, and understand how analyses of these inquiries support other GMA strategiesand tactics Clearly elucidate the role of the MSL Strategy team in the Global organization, and the implementation ofthe GMA strategies at the country level by field medical teams Understand the role of Patient Engagement & Partnerships in the GMA organization by supporting keypatient engagement initiatives across various medical teamsJustine Panicker, PharmD, RPhNortheastern University2nd Year Fellow 12 months will be spent across Scientific Communications, Publications and Medical Inquiries. Another 12months will be spent across MSL Strategy, Patient Engagement and Partnership, and Elective RotationRavi Patel, PharmDUniversity of Illinois at Chicago1st Year Fellow2022-2023 Fellowship Program20

Bayer Pharmaceuticals DivisionBusiness Development & Licensing2 YEAR FELLOWSHIPRECRUITING 2 FELLOWS Proactively identify BD&L opportunities to strengthen the U.S. portfolio by conducting in-depthlandscape assessments Leverage Pharmacy Doctorate to interpret scientific and medical information to further assessattractiveness of target opportunities for in-licensing, acquisitions, and partnering deals acrossmultiple Bayer therapeutic areas (e.g. oncology, nephrology, cardiology, women's health) Actively collaborate with global and cross-functional teams across the organization includingNew Product Commercialization, Medical Affairs, Regulatory Affairs, Intellectual Property,Marketing, Market AccessFrederick Nelson, MBAHead, Business Development & Licensing - U.S. RegionPreceptor Integrate market and commercial data to support evaluation of portfolio developmentopportunities Work and assist on all phases of BD&L deals, including business case ideation, financialevaluation, deal terms and contract negotiation Develop and maintain relationships and collaborations with current and potential externalpartners including partner alliance management activities and meetings with external parties toreview and discuss new BD&L opportunities Present deal opportunity analysis and recommendations to senior Bayer executivesKatie Brinn, PharmD, RPhMedical University of South Carolina Schoolof Pharmacy2nd Year FellowRyan Delacruz, PharmD, RPhUniversity of Washington School ofPharmacy2nd Year Fellow2022-2023 Fellowship Program21

Bayer Pharmaceuticals DivisionGlobal Oncology Training and Commercial Excellence2 YEAR FELLOWSHIPRECRUITING 1 FELLOWEnhance your understanding of the Learning and Development (L&D) strategy and activities for the global commercialpharmaceutical organization: Collaborate with global cross-functional teams (e.g. marketing, medical affairs, market research, local country teams)to understand training needs and identify necessary training solutions for launch and marketed products in the BayerOncology portfolio Leverage clinical expertise in the development of training materials, including scientific modules and skill-based workshops,which enable sales consultants to engage HCPs and health organizations in identifying appropriate patients for Bayerproducts in the context of the treatment landscapeAdrienne MagirlDirector, Global Oncology Training &Commercial ExcellencePreceptor- Evaluate key performance indicators (e.g. market research results) to develop focused training programs thatenhance sales force effectiveness- Maintain commercial and medical alignment to support brand strategy and scientific accuracy- Identify relevant content from competitive landscape considerations and key insights from thought leaders Execute the delivery of training solutions through various communication channels and events, including webconferencesand live training events Support the development of annual training plans and budget to support brand strategy and country execution needsNoteworthy Professional Development:Audrey Khoury, PharmD, RPhWayne State University2nd Year Fellow- Improved stakeholder management- Clear, effective, audience-agnostic communication skills- Enhanced scientific acumen (in the oncology space, as well as the commercial operations of a pharmaceuticalorganization)- Project and relationship management with agenciesPotential to complete a rotational assignment on an Oncology marketing or medical team2022-2023 Fellowship Program22

Bayer Pharmaceuticals DivisionNew Product Commercialization & Portfolio Strategy2 YEAR FELLOWSHIPRECRUITING 1 FELLOWThe New Product Commercialization and Portfolio Strategy (NPC&PS) team at Bayer is responsible for developing the earlycommercial strategy for pipeline assets. The NPC&PS team collaborates with multiple stakeholders across key functionsto assess and align on pivotal inputs critical to building strategy. Our mission is to amplify “one US voice” to shape Bayer’spipeline assets and portfolio strategy, ensuring value maximization and sustainability to reach mid- and long-term growthand profitability goals, aligned with the global team. The fellow will have the opportunity to be mentored by all membersof the NPC&PS team who have a wide variety of experiences across different functional and therapeutic areas within theindustry. Responsibilities of the fellow include the following:Yasmin Islami, MBAVP & Head, New Product Commercialization &Portfolio StrategyExecutive Sponsor Assist the U.S. Pharma business in ensuring optimal commercial and marketing input is provided and pulled throughthe global development programs, across various prioritized therapeutic areas Develop business cases and forecasts for compounds throughout development in order to ensure commercial viabilityof future products Assist in the evaluation and development of the U.S. commercial position on business development and licensingopportunities Manage market research and competitive intelligence projects to assess pipeline compounds on TPPs (target productprofiles), revenue forecasts, market differentiation, and commercialization opportunities and challenges Perform ad hoc analyses of market trends and insights to maximize commercial value of p

Consumer Health Program. Bayer Consumer Health, with its U.S. headquarters in Whippany, New Jersey, is among the top consumer healthcare . companies in the world. At Bayer's Consumer Health division, our vision is to make self-care for a better life a reality for . billions of people around the world through everyday healthcare.